BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 15, 2013
View Archived Issues
Bivalent norovirus vaccine protects against illness in oral challenge study
Read More
Varicella zoster vaccine candidate is immunogenic in patients with HIV infection
Read More
CD151 antigen expression correlated with progression in advanced gastric cancer
Read More
Bioengineering of a novel nanotechnology-based drug delivery system
Read More
Rational computational design of high-affinity, small-molecule-selective binding proteins
Read More
Anxiolytic activity demonstrated for RU-476
Read More
Mesoblast acquires Osiris' culture-expanded mesenchymal stem cell business
Read More
Novel photoimmunoconjugates discovered by German group
Read More
Researchers disclose new monoclonal antibodies for cancer and ocular disorders
Read More
Takeda Pharmaceutical prepares novel GL-R antagonists for diabetes
Read More
CCI Corporation patents new agents for cancer
Read More
New Aurora kinase inhibitors synthesized at Sunshine Lake Pharma
Read More
Clavis Pharma becomes Aqualis
Read More
Alcobra presents new findings on MG-01CI
Read More
Protalix BioTherapeutics reports phase I data for PRX-112
Read More
MannKind resubmits Afrezza NDA
Read More
Topline data from phase II TRUST-I trial in Crohn's disease reported
Read More
FDA releases drug safety communication for ponatinib
Read More
Otrexup injection approved by the FDA for several indications
Read More
Cellceutix plans to begin phase IIb trial of Brilacidin in 2014
Read More
Boehringer Ingelheim and Lilly submit application in Japan for empagliflozin
Read More
Acacia Pharma's phase II trial of APD-515 for xerostomia meets primary endpoint
Read More
Immatics raises funds to complete development of IMA-901 for renal cancer
Read More
Janssen files MAA with EMA for fixed-dose combination of darunavir and cobicistat
Read More
MedImmune acquires biotech company and invests in ADC Therapeutics
Read More
